KarinCA Saturday, 10/07/17 04:10:36 PM Re: codaras post# 4 Post # of 46 Mitochondria based therapeutics (MBTs) are the rage these days. Many scientists/companies are doing research in this arena. That's why I wasn't in a hurry to do the research for a couple more weeks. I don't feel in a hurry since I thought the price was too high for where they are now. Apparently, others feel differently. It would have been a great flip from the day I created this board. Here's a google search on mitochondria based therapeutics. https://www.google.com/search?q=mitochondria+based+therapeutics&rlz=1C1EODB_enUS533US533&oq=mitochondria+based+therapeutics&aqs=chrome..69i57j0.12632j0j8&sourceid=chrome&ie=UTF-8 You'll find a lot of work listed on pubmed also. https://www.ncbi.nlm.nih.gov/pubmed/?term=mitochondria+based+therapeutics https://www.ncbi.nlm.nih.gov/pubmed/?term=mitochondria+genome https://www.ncbi.nlm.nih.gov/pubmed/?term=mitochondria+peptides I'm hoping to find their preclinical data. From the prospectus dated Oct 5, 2017: https://www.sec.gov/Archives/edgar/data/1522602/000121390017010315/f424b3100517_cohbarinc.htm Quote:All of our pipeline MDPs and MBT candidates are in the pre-clinical stage of development We are looking at this very early since there hasn't been a ph1 safety trial yet on any of their drug candidates. Was a trial start date mentioned in the call? Has an IND been submitted to the FDA? It will be interesting to follow their progress. All of these companies targeting anti-aging and healthspan are of great interest to me. It seems that diabetes and alzheimer's are common targets for them. To follow KarinCA, click here then click "Follow This Member" under my photo. Be kinder than necessary, for everyone you meet is fighting some kind of battle.